In just a week of time, a CD38 monoclonal antibody–daratumumab (Darzalex, Janssen)- has been reported twice to markedly reduce disease progression b...
The detailed findings of the study was presented on 5-June in 2016, by the lead investigator Alan P Venook, MD, professor of medicine at the Universit...
EMPA-REG OUTCOME trial was the first positive FDA-mandated cardiovascular (CV) outcome study for anti-hyperglycemia medicine reported last fall.1 Yet,...
This is the second FDA-mandated cardiovascular (CV) outcome study for anti-hyperglycemic medicine showing positive results after the EMPA-REG trial of...
FIT is a common modality for colorectal cancer (CRC) screening; positive tests require a follow-up diagnostic colonoscopy. However, little is known ab...
TAF is an investigational treatment (Gilead Sciences) for CHB while TDF is an approved treatment option and is one of the two guideline-recommended nu...
Not all breast cancer relapse after treatment, but why some relapse while some do not? A group of cancer researchers from Wellcome Trust Sanger Instit...
There might be niche for specific bevacizumab-containing regimen with more favourable survival (OS) advantage in locally recurrent/ metastatic breast ...
Chronic constipation (CC) is associated with a number of serious gastrointestinal (GI) disorders, including colorectal cancer (CRC), gastric cancer an...
For the first time with clear and positive evidence, women with early breast cancer treated with accelerated partial-breast irradiation (APBI) did equ...
